I think the impairments probably relate more to accounting treatment. Although I am no expert of accounting rules I believe there would be an impact on holding R&D expenditure for example as an asset on your balance sheet if the likelihood of receiving revenue moved from 2 years to 6 years. I wouldn't read too much into the impairment as I believe it would be accounting rule related to the delay.
i am the iceman!
- Forums
- ASX - By Stock
- SLX
- cameco Q2
cameco Q2, page-3
Featured News
Add SLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.46 |
Change
-0.070(1.55%) |
Mkt cap ! $1.058B |
Open | High | Low | Value | Volume |
$4.53 | $4.62 | $4.46 | $991.9K | 219.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1020 | $4.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.49 | 308 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1020 | 4.460 |
6 | 4938 | 4.450 |
1 | 214 | 4.440 |
2 | 1734 | 4.430 |
2 | 1734 | 4.420 |
Price($) | Vol. | No. |
---|---|---|
4.490 | 308 | 1 |
4.510 | 1520 | 1 |
4.520 | 1734 | 2 |
4.530 | 1734 | 2 |
4.540 | 1734 | 2 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |